The skin and vaccination against smallpox.
D000917:Antibody Formation; D000998:Antiviral Agents / Q000627:therapeutic use; D004345:Drug Industry; D004355:Drug Stability; D004485:Eczema / Q000175:diagnosis; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D008854:Microscopy, Electron; D009336:Necrosis / Q000209:etiology; D011247:Pregnancy; D012871:Skin Diseases / Q000209:etiology*; D012899:Smallpox / Q000517:prevention & control*; D012900:Smallpox Vaccine; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014611:Vaccination / Q000009:adverse effects*; D014615:Vaccinia / Q000175:diagnosis; D014616:Vaccinia virus / Q000302:isolation & purification; D014652:Vascular Diseases / Q000209:etiology
D000998:Antiviral Agents; D012900:Smallpox Vaccine; D013882:Thiosemicarbazones